MedTrace Logo

Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension

NCT07305922 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-12-26

No results posted yet for this study

Summary

An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.

Conditions

  • Subarachnoid Aneurysm Hemorrhage
  • Cerebral Vasospasm After Subarachnoid Hemorrhage

Interventions

DRUG

Induced hypertension with norepinephrine

Induced hypertension with norepinephrine and/or dobutamine to attain clinically established goals of cerebral perfusion pressure in a stepwise fashion, according to clinical routine.

DRUG

Endoluminal Spasmolysis

Endoluminal spasmolysis of cerebral arteries using i.a. Nimodipine, according to clinical protocol and neurointerventionist discretion.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07305922 on ClinicalTrials.gov